Spectral AI (MDAI) Set to Announce Quarterly Earnings on Tuesday

Spectral AI (NASDAQ:MDAI) is expected to release its Q3 2026 results after the market closes on Tuesday, November 10th. Analysts expect the company to post earnings of ($0.14) per share and revenue of $5.33 million for the quarter. Parties are encouraged to explore the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Tuesday, November 10, 2026 at 5:00 PM ET.

Spectral AI (NASDAQ:MDAI) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.01. The firm had revenue of $3.52 million for the quarter, compared to analysts’ expectations of $4.17 million. On average, analysts expect Spectral AI to post ($0.50) EPS for the current fiscal year and ($0.31) EPS for the next fiscal year.

Spectral AI Stock Up 1.0%

MDAI stock traded up $0.01 during trading on Tuesday, reaching $1.53. The stock had a trading volume of 57,236 shares, compared to its average volume of 444,410. The company has a market capitalization of $49.41 million, a price-to-earnings ratio of -4.39 and a beta of 1.21. Spectral AI has a one year low of $1.18 and a one year high of $2.97. The company’s 50 day moving average is $1.59 and its two-hundred day moving average is $1.70.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on MDAI shares. Northland Securities upgraded shares of Spectral AI to a “strong-buy” rating in a research note on Monday, July 27th. Wall Street Zen upgraded shares of Spectral AI from a “sell” rating to a “hold” rating in a research note on Saturday, September 12th. Finally, Weiss Ratings raised shares of Spectral AI from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, October 28th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $4.00.

About Spectral AI

Spectral AI, Inc is a medical diagnostic technology company focused on using artificial intelligence and advanced imaging to support earlier, more objective assessment of wound healing. The company develops predictive diagnostic systems intended to help clinicians evaluate wounds and make treatment decisions.

Its principal product is the DeepView System, a noninvasive imaging and artificial intelligence platform designed to assess burn wounds and predict the likelihood that injured tissue will heal without surgical intervention.